Search for: "ALLERGAN, INC." Results 81 - 100 of 381
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jul 2018, 2:38 pm by Jason Rantanen
By Jason Rantanen Saint Regis Mohawk Tribe, Allergan, Inc. v. [read post]
23 Jul 2018, 12:05 pm by Dennis Crouch
Procedure – Impact of Factual Stipulation: Allergan Sales, LLC v. [read post]
20 Jul 2018, 11:44 pm by Lawrence B. Ebert
The outcome:Mylan Pharmaceuticals, Inc., petitioned for interpartes review (“IPR”) of various patents owned by Allergan,Inc., relating to its dry eye treatment Restasis. [read post]
13 Jun 2018, 11:39 pm by Jon Gelman
The Sackler family has sole ownership of Purdue and holds the majority of the seats on Purdue Pharma Inc. [read post]
24 Feb 2018, 10:12 am by Lawrence B. Ebert
” Speedplay, Inc. v.Bebop, Inc., 211 F.3d 1245, 1250 (Fed. [read post]
3 Jan 2018, 5:10 am
On the heels of the Ericsson decision, further briefing on the waiver issue was recently authorized in Mylan Pharmaceuticals Inc., et al. v. [read post]
26 Dec 2017, 5:00 am by John Jascob
Massey, Pyott (Allergan), and Westmoreland (a Seventh Circuit case involving Baxter International).The case is No. 12151-VCG. [read post]
19 Dec 2017, 9:59 pm by Patent Docs
But today, an expanded panel of the Board, including Chief Judge David Ruschke, issued an order dismissing a sovereign immunity challenge by the State of Minnesota in Ericsson Inc. and Telefonaktiebolaget LM Ericsson v. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
16 Nov 2017, 6:17 am
Posted by Dan Marcec, Equilar Inc., on Thursday, November 16, 2017 Editor's Note: Dan Marcec is Director of Content at Equilar, Inc. [read post]
9 Nov 2017, 4:00 am by Alan Macek
Allergan Inc., 2012 FCA 308), the court did look to the description, to incorporate an improved safety profile into the inventive concept, even though there was no explicit reference to the safety profile in the claim language. [read post]